2021年5月26日 · Haje and Jablonski are both charged with conspiracy to defraud the United States, in violation of 18 U.S.C. § 371. Haje also is charged with conspiracy to commit health care fraud, in violation of 18 U.S.C. § 1349. If convicted, the defendants face the following statutory maximum sentences:

CLERKS NOTICE CONVERTING HEARING TO ZOOM HEARING. Change of Plea as to Paul Haje Hearing is set for 8/9/2021 01:30 PM in San Jose, - Videoconference Only before Judge Edward J. Davila.

2023年4月29日 · Haje informed the jury that he had pleaded guilty to conspiring with Defendant and others, including Renee Schena, Dan Williams, Marc Jablonski, and Dr. Taguchi, to submit false and fraudulent claims to government insurers, including Medicare and TRICARE, and to private insurers. 8/11/22 Trial Tr. 1282:7-1285:7.

2022年6月22日 · Haje and Jablonski were charged with conspiracy to defraud the United States and pay and receive kickbacks, and Haje was also charged with conspiracy to commit health care fraud. If found guilty of all charges, Schena faces up to 65 years in prison, Haje faces up to 25 years in prison, and Jablonski faces up to 5 years.

2021年5月26日 · A federal grand jury handed down a superseding indictment against the president of California-based medical technology company Arrayit Corporation, Mark Schena, in connection with the submission of over $70 million in false and fraudulent claims for allergy and COVID-19 testing.

2021年5月30日 · Arrayit Vice President of Marketing Paul Haje and Marc Jablonski, described by the U.S. Attorney’s Office in San Francisco as the president of an Arizona-based marketing organization, are also...

San Francisco, California – A grand jury returned a superseding indictment charging Mark Schena, the president of Arrayit Corporation, a California-based medical technology company, in relation to the submission of more than 70 million U.S. dollars in false claims for allergy and COVID-19 testing.

2021年5月26日 · SAN FRANCISCO –A federal grand jury handed down a superseding indictment against the president of California-based medical technology company Arrayit Corporation, Mark Schena, in connection with the submission of over $70 million in false and fraudulent claims for allergy and COVID-19 testing.

2015年3月24日 · Paul Haje, director of sales and marketing at Arrayit, told GenomeWeb at the time that the Array Molecular arrangement was "associated with a deal Arrayit is involved in with the US government," but declined to comment further. He also said that Arrayit had agreed to provide Array Molecular with instruments and consumables.

Paul Haje, director of sales and marketing at Arrayit, confirmed with BioArray News this week that the case had been dismissed with prejudice but declined to further elaborate. Of note, Arrayit also said in its SEC filing this week that it signed a contract last month providing for the supply of technology to Array Molecular, which is owned by ...